Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

The following seven leading European stocks all offer significant scale, along with insulation from U.S. market volatility ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

Nasal Polyps Treatment Market Research Report The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030 ...

In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

This story was originally published . Sign up for their newsletters. By Adam Echelman and Erica Yee, CalMatters $390,000 to ...

European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.21% to 1,391.26 on the S&P Europe Select ADR Index. From continental Europe, the ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,624.35 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...